Nanjing Hicin Pharmaceutical Co Ltd Strategic Asset Allocation Index
Nanjing Hicin Pharmaceutical Co Ltd strategic asset allocation index. Nanjing Hicin Pharmaceutical Co Ltd (300584) has a Strategic Asset Allocation Index of 58.7% as of June 2023. Strategic assets (PP&E of CN¥569.89 Million plus long-term investments of CN¥-) total CN¥569.89 Million, measured against net assets of CN¥970.16 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check tangible net worth ratio of Nanjing Hicin Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Nanjing Hicin Pharmaceutical Co Ltd (2012–2022)
Strategic asset allocation index of Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2022. This chart shows how Nanjing Hicin Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 58.7%, representing strategic assets of CN¥569.89 Million against net assets of CN¥970.16 Million CNY.
Nanjing Hicin Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2012–2022)
Nanjing Hicin Pharmaceutical Co Ltd strategic asset allocation index by year from 2012 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Nanjing Hicin Pharmaceutical Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 53.2% | CN¥505.53 Million | CN¥505.53 Million | CN¥- | CN¥950.57 Million | ▲ +14.1 pp |
| 2021 | 39.1% | CN¥370.75 Million | CN¥370.75 Million | CN¥- | CN¥948.48 Million | ▼ -6.7 pp |
| 2020 | 45.8% | CN¥310.81 Million | CN¥310.81 Million | CN¥- | CN¥678.97 Million | ▼ -2.2 pp |
| 2019 | 48.0% | CN¥313.84 Million | CN¥313.84 Million | CN¥- | CN¥653.98 Million | ▼ -30.2 pp |
| 2018 | 78.2% | CN¥454.14 Million | CN¥323.87 Million | CN¥130.28 Million | CN¥580.93 Million | ▲ +24.3 pp |
| 2017 | 53.9% | CN¥278.83 Million | CN¥278.03 Million | CN¥800.00K | CN¥517.68 Million | ▼ -27.1 pp |
| 2016 | 80.9% | CN¥223.49 Million | CN¥223.49 Million | CN¥- | CN¥276.11 Million | ▲ +5.4 pp |
| 2015 | 75.6% | CN¥177.63 Million | CN¥177.63 Million | CN¥- | CN¥235.08 Million | ▼ -0.3 pp |
| 2014 | 75.9% | CN¥151.93 Million | CN¥151.93 Million | CN¥- | CN¥200.15 Million | ▼ -3.9 pp |
| 2013 | 79.8% | CN¥132.47 Million | CN¥132.47 Million | CN¥- | CN¥165.93 Million | ▲ +23.8 pp |
| 2012 | 56.0% | CN¥74.33 Million | CN¥74.33 Million | CN¥- | CN¥132.65 Million | — |